Understanding diabetes medications from the perspective of patients with type 2 diabetes - Prerequisite to medication concordance

被引:57
作者
Hayes, Risa P.
Bowman, Lee
Monahan, Patrick O.
Marrero, David G.
McHorney, Colleen A.
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Global Hlth Outcomes Res, Indianapolis, IN 46285 USA
[2] Indiana Univ, Sch Med, Dept Med, Div Biostat, Indianapolis, IN USA
[3] Indiana Univ, Sch Med, Div Endocrinol & Metab, Indianapolis, IN USA
[4] Merck & Co Inc, Outcomes Res & Management, West Point, PA USA
关键词
D O I
10.1177/0145721706288182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The purpose of this qualitative study was to explore diabetes medication experiences of patients with type 2 diabetes. Methods Study participants were recruited through newspaper advertisements and letters from primary and specialty clinics in Indianapolis, Indiana. The same professional facilitator conducted 18 focus groups (7 male, 11 female) at a Veteran Affairs facility in Indianapolis, Indiana. Participants were 138 socioeconomically diverse individuals with type 2 diabetes (68% female, 74% >= 50 years old, 61% non-Hispanic Caucasian). Participants were on a variety of diabetes medication regimens (61% injectable insulin monotherapy or in combination with orals). Content analysis of focus group transcripts was used to establish themes. Results Three major themes emerged across the focus groups: (1) the inconvenience and inflexibility of the timing and frequency of administration of many diabetes treatments on participants' lives, (2) the desire to avoid injections and/or insulin therapy, and (3) the physical and emotional side effects of diabetes medications. Assuming equivalent effectiveness of 2 medications, participants would weigh the convenience and flexibility, route of administration, side effects, and cost of the medications to arrive at a treatment preference. Participants believed they currently had no opportunity to express their treatment preference to their health care provider. Conclusions The best therapeutic option for a patient with type 2 diabetes will be one that is clinically effective and consistent with the patient's needs and preferences. The challenge for diabetes educators is to support patients in articulating and incorporating their needs and preferences into the treatment decision-making process.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 40 条
[1]   Compliance and adherence are dysfunctional concepts in diabetes care [J].
Anderson, RM ;
Funnell, MM .
DIABETES EDUCATOR, 2000, 26 (04) :597-+
[2]   Using focus groups to identify psychosocial issues of urban black individuals with diabetes [J].
Anderson, RM ;
Barr, PA ;
Edwards, GJ ;
Funnell, MM ;
Fitzgerald, JT ;
Wisdom, K .
DIABETES EDUCATOR, 1996, 22 (01) :28-33
[3]   Patient empowerment: reflections on the challenge of fostering the adoption of a new paradigm [J].
Anderson, RM ;
Funnell, MM .
PATIENT EDUCATION AND COUNSELING, 2005, 57 (02) :153-157
[4]  
Berelson B.R., 1954, Handbook of Social Psychology: Theory and Method, P488
[5]  
BROOKS A, 2004, 40 ANN M EUR ASS STU
[6]   Treatment satisfaction in type 2 diabetes: A comparison between an inhaled insulin regimen and a subcutaneous insulin regimen [J].
Cappelleri, JC ;
Cefalu, WT ;
Rosenstock, J ;
Kourides, IA ;
Gerber, RA .
CLINICAL THERAPEUTICS, 2002, 24 (04) :552-564
[7]   Concept, strategies, and feasibility of noninvasive insulin delivery [J].
Cefalu, WT .
DIABETES CARE, 2004, 27 (01) :239-246
[8]   Medication concordance is best helped by improving consultation skills [J].
Chen, J .
BRITISH MEDICAL JOURNAL, 1999, 318 (7184) :670-671
[9]   SAFETY, EFFICACY, ACCEPTABILITY OF A PRE-FILLED INSULIN PEN IN DIABETIC-PATIENTS OVER 60 YEARS OLD [J].
COSCELLI, C ;
LOSTIA, S ;
LUNETTA, M ;
NOSARI, I ;
CORONEL, GA .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (03) :173-177
[10]  
de Grauw WJC, 2001, BRIT J GEN PRACT, V51, P527